42,00,000(70.0%)
18,00,000(30.0%)
60,00,000
Om Megashree Pharmaceuticals Limited is a pharmaceutical manufacturing and processing company in Nepal, established on June 12, 2016 as a private limited company and converted to a public limited company in July 2022. It operates a manufacturing facility in Bharatpur, Chitwan, producing medicines for human and veterinary use, including cardiovascular, diabetes, digestive and antibiotic products under cGMP standards. It was listed on the Nepal Stock Exchange on April 30, 2025 under the symbol OMPL, noted as among the first pharmaceutical companies listed on NEPSE.
Om Megashree Pharmaceuticals Limited (OMPL) is listed under "Manufacturing And Processing" sector at Nepal Stock Exchange (NEPSE) on April 30, 2025 with a market capitalization of NPR 4,83,60,00,000 (4.8 Arab) and a float market capitalization of NPR 1,45,08,00,000 (1.5 Arab). It has a total of 60,00,000 (60 Lakh) listed shares, of which 42,00,000 (42 Lakh) (70%) are promoter shares and 18,00,000 (18 Lakh) (30%) are public shares.
By market capitalization, Om Megashree Pharmaceuticals Limited (OMPL) ranks #15 of 18 actively traded Manufacturing And Processing companies on NEPSE.
Om Megashree Pharmaceuticals Limited (OMPL) has a total market capitalization of NPR 4,83,60,00,000 (4.8 Arab) and a float market capitalization of NPR 1,45,08,00,000 (1.5 Arab). The book value stands at 90.17, resulting in a price-to-book value (PBV) of 8.94. The face value of each share is Rs. 100.
A total of 60,00,000 (60 Lakh) shares of Om Megashree Pharmaceuticals Limited (OMPL) are listed in NEPSE, of which 42,00,000 (42 Lakh) (70%) are promoter shares and 18,00,000 (18 Lakh) (30%) are public shares.
As of October 12, 2026, the latest trading price (LTP) of Om Megashree Pharmaceuticals Limited (OMPL) is Rs. 809 (-11, -1.34%). Today, the stock opened at Rs. 820, reached a high of Rs. 844.6, and a low of Rs. 806. The previous closing price was Rs. 820, with a turnover of Rs. 652536.8 and a trading volume of 801 shares across 27 trades.
Over the past year, Om Megashree Pharmaceuticals Limited (OMPL) has seen a 52-week high of Rs. 1575.9 and a low of Rs. 806. The all-time high was Rs. 2167.2 on June 05, 2025, while the all-time low was Rs. 270 on May 04, 2025. The 120-day average price is Rs. 1009.02, and the 180-day average is Rs. 1117.62. The 1-year yield is currently -26.79%.
Om Megashree Pharmaceuticals Limited (OMPL) has an earnings per share (EPS) of 3.3 and a P/E ratio of 244.24. The book value per share is 90.17, and the price-to-book value (PBV) is 8.94. The stock's 1-year yield is -26.79%, and its fiscal year data is reported for 080/81, Q4. The paid-up capital is Rs. 60,00,00,000.
When Om Megashree Pharmaceuticals Limited (OMPL) listed on the Nepal Stock Exchange (NEPSE) on April 30, 2025, the opening price range for its first trading day, as per NEPSE guidelines, was between Rs 90.17 and Rs 270.51.
Om Megashree Pharmaceuticals Limited (OMPL) was listed on the Nepal Stock Exchange (NEPSE) on April 30, 2025 under the Manufacturing And Processing sector.
By market capitalization, Om Megashree Pharmaceuticals Limited (OMPL) ranks #15 of 18 actively traded Manufacturing And Processing companies listed on NEPSE. Its last traded price of Rs 809 sits at about 0% of the way between its 52-week low of Rs 806 and 52-week high of Rs 1575.9.
The promoter unlocking date for Om Megashree Pharmaceuticals Limited (OMPL) is on March 25, 2028. This date marks the end of the lock-in period for the company's promoter (eligible promoters, local people, employees etc.) shares, allowing promoters to trade them freely on the stock exchange.
